title: Response to Surawicz et al.
authors.affiliation: Cubist Pharmaceuticals, Lexington, Massachusetts, USA.
authors.forename: Sherwood
authors.initials: S
authors.lastname: Gorbach
authors.affiliation: Cubist Pharmaceuticals, Lexington, Massachusetts, USA.
authors.forename: C Andrew
authors.initials: CA
authors.lastname: DeRyke
authors.affiliation: Cubist Pharmaceuticals, Lexington, Massachusetts, USA.
authors.forename: Pamela
authors.initials: P
authors.lastname: Sears
mesh_terms: D016360:Clostridioides difficile / Q000302:isolation & purification*; D004761:Enterocolitis, Pseudomembranous; D006801:Humans; D017410:Practice Guidelines as Topic